Van Gent Jan-Michael, Clements Thomas W, Lubkin David E, Kaminski Carter W, Bates Jonathan K, Sandoval Mariela, Puzio Thaddeus J, Cotton Bryan A
Division of Trauma and Surgical Critical Care, The University of Texas Health Science Center at Houston, Houston, Texas, USA.
The University of Texas Health Science Center at Houston, Houston, Texas, USA.
Trauma Surg Acute Care Open. 2024 Apr 22;9(1):e001297. doi: 10.1136/tsaco-2023-001297. eCollection 2024.
Venous thromboembolism (VTE) risk reduction strategies include early initiation of chemoprophylaxis, reducing missed doses, weight-based dosing and dose adjustment using anti-Xa levels. We hypothesized that time to initiation of chemoprophylaxis would be the strongest modifiable risk for VTE, even after adjusting for competing risk factors.
A prospectively maintained trauma registry was queried for patients admitted July 2017-October 2021 who were 18 years and older and received emergency release blood products. Patients with deep vein thrombosis or pulmonary embolism (VTE) were compared to those without (no VTE). Door-to-prophylaxis was defined as time from hospital arrival to first dose of VTE chemoprophylaxis (hours). Univariate and multivariate analyses were then performed between the two groups.
2047 patients met inclusion (106 VTE, 1941 no VTE). There were no differences in baseline or demographic data. VTE patients had higher injury severity score (29 vs 24), more evidence of shock by arrival lactate (4.6 vs 3.9) and received more post-ED transfusions (8 vs 2 units); all p<0.05. While there was no difference in need for enoxaparin dose adjustment or missed doses, door-to-prophylaxis time was longer in the VTE group (35 vs 25 hours; p=0.009). On multivariate logistic regression analysis, every hour delay from time of arrival increased likelihood of VTE by 1.5% (OR 1.015, 95% CI 1.004 to 1.023, p=0.004).
The current retrospective study of severely injured patients with trauma who required emergency release blood products found that increased door-to-prophylaxis time was significantly associated with an increased likelihood for VTE. Chemoprophylaxis initiation is one of the few modifiable risk factors available to combat VTE, therefore early initiation is paramount. Similar to door-to-balloon time in treating myocardial infarction and door-to-tPA time in stroke, "door-to-prophylaxis time" should be considered as a hospital metric for prevention of VTE in trauma.
Level III, retrospective study with up to two negative criteria.
静脉血栓栓塞症(VTE)风险降低策略包括早期启动化学预防、减少漏服剂量、基于体重给药以及使用抗Xa水平进行剂量调整。我们假设,即使在调整了竞争风险因素之后,启动化学预防的时间仍将是VTE最强的可改变风险因素。
查询前瞻性维护的创伤登记数据库,纳入2017年7月至2021年10月期间入院的18岁及以上且接受了紧急发放血制品的患者。将发生深静脉血栓形成或肺栓塞(VTE)的患者与未发生VTE的患者进行比较。从入院到预防用药的时间定义为从医院到达至首次给予VTE化学预防药物的时间(小时)。然后对两组进行单因素和多因素分析。
2047例患者符合纳入标准(106例发生VTE,1941例未发生VTE)。基线或人口统计学数据无差异。发生VTE的患者损伤严重程度评分更高(29分对24分),到达时乳酸水平提示休克的证据更多(4.6对3.9),且急诊后接受的输血更多(8单位对2单位);所有p<0.05。虽然在依诺肝素剂量调整需求或漏服剂量方面没有差异,但VTE组从入院到预防用药的时间更长(35小时对25小时;p=0.009)。在多因素逻辑回归分析中,从到达时间起每延迟一小时,发生VTE的可能性增加1.5%(比值比1.015,95%置信区间1.004至1.023,p=0.004)。
目前对需要紧急发放血制品的严重创伤患者进行的回顾性研究发现,从入院到预防用药的时间增加与VTE发生可能性增加显著相关。启动化学预防是对抗VTE为数不多且可改变的风险因素之一,因此早期启动至关重要。类似于治疗心肌梗死时的门球时间和治疗卒中时的门到组织型纤溶酶原激活剂时间,“从入院到预防用药时间”应被视为创伤患者预防VTE的一项医院指标。
III级,具有多达两个阴性标准的回顾性研究。